Key Highlights:
- Cambridge Cognition Holdings partnered with Ivory to commercialize its digital cognitive assessment platform CANTAB Pathway across healthcare and consumer health markets in India, expanding access to early screening tools for cognitive decline.
- India represents a major opportunity for brain health screening with a population of ~1.47B people, including ~138M individuals aged over 60, of whom up to 34M may be living with mild or major cognitive impairment, while research suggests that nearly 90% of cases remain undiagnosed.
- Through Ivory’s growing clinical network and consumer platform, CANTAB Pathway will enable scalable early screening and proactive brain health monitoring. The assessments are currently available in English, Hindi, Tamil, Telugu, Bengali, and Kannada, with further language expansion planned.
Implications:
CANTAB’s India entry taps the $1B+ digital diagnostics market (25% CAGR), challenging manual screening while accelerating early dementia detection amid aging demographics.
Ivory’s network could screen 5-10M undiagnosed cases in 3 years, pressuring traditional neurology clinics interest in AI-cognitive platforms.
Success positions India as Asia’s brain health screening hub, boosting digital health exports to Saudi/Gulf markets with similar elderly demographics.
Source: Businesswire
Other Articles
Next
February 17, 2026
No Comment! Be the first one.